273 Usefulness of sonovue microbubble-enhanced ultrasonography in the assessment of the efficacy of percutaneous ablation in patients with hepatocellular carcinoma

R. Vilana, Luís Bianchi, Marı́a Varela, Carlos Nicolau, Marcelo Sánchez, Carmen Ayuso, Montserrat García, María Sala, Josep M. Llovet, Jordi Bruix, Brú C

European Radiology

Article2001

Tumor dissemination after radiofrequency ablation of hepatocellular carcinoma

Josep M. Llovet, R. Vilana, Concepció Brú, Lluís Bianchi, Jordi Bruix

Hepatology

Article2003

Percutaneous treatment for unresectable hepatocellular carcinoma. Predictors of long-term survival of 274 patients in a single institution

Margaret Sala, Josep M. Llovet, R. Vilana, Lluís Bianchi, Carmen Ayuso, C. Brú, Jordi Bruix

Journal of Hepatology

Letter2017

Reply to: “Predictors of sorafenib benefit in patients with hepatocellular carcinoma”

Jordi Bruix, Ann‐Lii Cheng, Josep M. Llovet

Journal of Hepatology

Article2001

Chemoembolization improves survival in patients with unresectable hepatocellular carcinoma (HCC)

Josep M. Llovet, María Isabel Real, R. Vilana, Ramón Planas, S. Coll, John J. Aponte, Carmen Ayuso, María Sala, Jordi Muchart, R. Costa, J Rodés, Jordi Bruix

Journal of Hepatology

273 Usefulness of sonovue microbubble-enhanced ultrasonography in the assessment of the efficacy of percutaneous ablation in patients with hepatocellular carcinoma

Abstract

Discussion(0)

Related publications

Is microbubble-enhanced ultrasonography sufficient for assessment of response to percutaneous treatment in patients with early hepatocellular carcinoma?

Tumor dissemination after radiofrequency ablation of hepatocellular carcinoma

Percutaneous treatment for unresectable hepatocellular carcinoma. Predictors of long-term survival of 274 patients in a single institution

Reply to: “Predictors of sorafenib benefit in patients with hepatocellular carcinoma”

Chemoembolization improves survival in patients with unresectable hepatocellular carcinoma (HCC)